The Effect of Adenomoyosis on Pregnancy Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-20

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adenomyosis can be defined as the settling of endometrial gland cells in the myometrium and deformity in the uterus and the prevalence of adenomyosis is according to the patient population and countries around 20%. There are recent publications reporting that this rate increases up to 50% in women dealing with infertility. In adenomyosis, where uterine morphology is affected, it is not thought that the uterus, which is expected to provide many morphological adaptations during pregnancy, will not be affected. Therefore, in this prospective study, it was planned to investigate the effects of adenomyosis during pregnancy.

For this study the presence of adenomyosis will be questioned by using ultrasonographic morphological uterine limitation (MUSA) in women who apply to the outpatient clinic with suspicion of pregnancy and undergo transvaginal ultrasonography for the diagnosis of pregnancy before sixth gestational week.

Patients will be divided into two groups according to the presence of adenomyosis and pregnancy complications such as preterm labor, premature rupture of membranes, cesarean section rates, preeclampsia, fetal malpresentation and preeclampsia will be compared between the groups.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adenomyosis and Pregnancy Outcomes in Women Undergoing Assisted Reproductive Technology Treatment

NCT05418140

Adenomyosis Infertility ART +2 more

ACTIVE_NOT_RECRUITING

Levonorgestrel Intrauterine System and Adenomyosis

NCT03104309

Adenomyosis

COMPLETED NA

Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis

NCT03520439

Adenomyosis

COMPLETED PHASE2/PHASE3

Norwegian Adenomyosis Study I

NCT02201719

Adenomyosis

COMPLETED

Histopathological Diagnosis of Adenomyosis

NCT02340533

Adenomyosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adenomyosis Pregnancy Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adenomyosis Group

Non intervention

Intervention Type OTHER

During the study there is no extra intervention planned for the participants.

Non-adenomyosis Group

Non intervention

Intervention Type OTHER

During the study there is no extra intervention planned for the participants.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non intervention

During the study there is no extra intervention planned for the participants.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18-35 years
* Being diagnosed before the 6th gestational week
* Having all pregnancy follow-ups and deliveries in our hospital

Exclusion Criteria

* Previous uterine surgery
* Multiple pregnancies
* Pregnant women with uterine malformations
* Pregnant women with fetal anomalies
* Those who got pregnant using assisted reproductive technique

Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes